Diagnostic Performance of Microvascular Imaging for Detecting Histologically Confirmed Liver Fibrosis in Autoimmune Hepatitis: Comparison with Transient Elastography and Serum Biomarkers
Authors:
- Nazugum AshimovaNANazugum Ashimova
- Aigul RaissovaARAigul Raissova
- Evgeniy YeninEYEvgeniy Yenin
- Rabiga KhozhamkulRKRabiga Khozhamkul
- Zhamilya ZholdybayZZZhamilya Zholdybay
- Maigul ShamshidinovaMSMaigul Shamshidinova
- Takhmina UsenovaTUTakhmina Usenova
- Andreas TeufelATAndreas Teufel
- Aigerim MustapayevaAMAigerim Mustapayeva
- Alexander NersesovANAlexander Nersesov
Open Access
- 2 July 2026
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (13) , 2072
Abstract
Background/Objectives: Autoimmune hepatitis (AIH) is a chronic immune-mediated liver disease that may progress to cirrhosis and liver failure if not diagnosed early. Although liver biopsy remains the reference standard for fibrosis assessment, its invasive nature limits routine use. This study aimed to compare the diagnostic performance of ultrasound-based microvascular imaging (MVI), transient elastography (TE), and serum fibrosis indices (APRI and FIB-4) in patients with biopsy-confirmed AIH. Methods: Fifty-five patients with probable or definite AIH according to IAIHG criteria were included in the study. All patients underwent liver biopsy, and fibrosis stage was assessed using the METAVIR system. TE and MVI examinations were performed, and APRI and FIB-4 scores were calculated. Diagnostic performance was evaluated using AUROC, sensitivity, and specificity. Spearman correlation and logistic regression analyses were additionally performed. Results: The mean age of the patients was 49.2 years, and most patients were women. Cirrhosis was present in 58.2% of the cohort. TE demonstrated high diagnostic accuracy, whereas FIB-4 showed moderate performance and APRI demonstrated limited utility. MVI achieved the highest diagnostic performance, with AUROC values of 0.99 for significant fibrosis and 0.97 for cirrhosis. MVI showed the strongest correlation with histological fibrosis stage (r = 0.916, p < 0.001), followed by TE (r = 0.907, p < 0.001). MVI was strongly associated with histologically confirmed cirrhosis (OR 16.7, 95% CI 2.36–118.2, p = 0.004). Conclusions: MVI demonstrates diagnostic performance comparable to TE and may represent a promising adjunctive non-invasive imaging biomarker for fibrosis assessment in AIH. Larger multicenter studies are required for external validation before routine clinical implementation.Keywords
Funding Information
- Asfendiyarov Kazakh National Medical University (0125PKИ0123)
This publication has 31 references indexed in Scilit:
- Diagnostic performance of microvascular flow imaging for noninvasive assessment of liver fibrosis in chronic liver diseasePLOS ONE, 2025
- The Utility of a Novel Stacked Microvascular Imaging for Enhanced Detection of Fibrosis in Chronic Liver DiseasesUltrasound in Medicine & Biology, 2024
- The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitisHepatology International, 2021
- Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitisHepatology International, 2018
- Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosisJournal of Hepatology, 2016
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology, 2015
- Liver biopsy†Hepatology, 2009
- Non-invasive evaluation of liver fibrosis using transient elastographyJournal of Hepatology, 2008
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995